Avelumab is indicated for:
Population group: both men and women, only adults (18 years old or older)
Avelumab is indicated as monotherapy for the treatment of adult patients with metastatic Merkel cell carcinoma (MCC).
For this indication, competent medicine agencies globally authorize below treatments (click for details):